Review: taking Lovenox and Testosterone cypionate together


Summary

Drug interactions are reported among people who take Lovenox and Testosterone cypionate together. This review analyzes the effectiveness and drug interactions between Lovenox and Testosterone cypionate. It is created by eHealthMe based on reports of 37 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lovenox

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. (latest outcomes from Lovenox 26,573 users)

Testosterone Cypionate

Testosterone cypionate has active ingredients of testosterone cypionate. It is often used in testosterone. (latest outcomes from Testosterone cypionate 448 users)

On Sep, 18, 2016

37 people who take Lovenox, Testosterone Cypionate are studied.


Number of reports submitted per year:

Lovenox and Testosterone cypionate drug interactions.

Drug effectiveness over time:

Lovenox:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Testosterone Cypionate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lovenox:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)
Testosterone Cypionate:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Lovenox:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Testosterone Cypionate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • back pain
  • cardiomyopathy
  • exostosis
  • gastric ulcer haemorrhage
  • hyponatraemia
  • post-traumatic stress disorder
1 - 6 months:
  • deep vein thrombosis
  • embolism venous
  • feeling abnormal
  • heart rate irregular
  • nervousness
  • pulmonary embolism
6 - 12 months:
  • anger
  • arrhythmia
  • arthritis
  • atrial fibrillation
  • atrial flutter
  • cardiomyopathy
  • chest pain
  • conjunctivitis viral
  • cough
  • deep vein thrombosis
1 - 2 years:
  • cognitive deterioration
  • depression
  • dizziness
  • fatigue - chronic
  • gait abnormal
  • hyperacusis
  • hyporeflexia
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • muscle twitching
  • myelomalacia
2 - 5 years:
  • cognitive deterioration
  • depression
  • dizziness
  • fatigue - chronic
  • gait abnormal
  • hyperacusis
  • hyporeflexia
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • muscle twitching
  • myelomalacia
not specified:
  • atrial fibrillation
  • hyperkalaemia
  • abdominal pain
  • acute generalised exanthematous pustulosis
  • deep vein thrombosis
  • dyspnoea
  • fall
  • pain
  • pulmonary embolism
  • cardiomyopathy

Most common drug interactions by gender *:

female:
  • pain
  • weight decreased
  • anxiety
  • blister
  • decreased appetite
  • depression
  • diarrhoea
  • drug hypersensitivity
  • dry mouth
  • hepatic enzyme increased
male:
  • sensory disturbance
  • atrial fibrillation
  • depression
  • dizziness
  • cognitive deterioration
  • fatigue - chronic
  • gait abnormal
  • hyperacusis
  • hyporeflexia
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness

Most common drug interactions by age *:

40-49:
  • abdominal pain
  • drug ineffective
  • fall
  • musculoskeletal pain
  • upper limb fracture
50-59:
  • sensory disturbance
  • dizziness
  • cognitive deterioration
  • depression
  • fatigue - chronic
  • gait abnormal
  • hyperacusis
  • hyporeflexia
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • muscle twitching
60+:
  • atrial fibrillation
  • acute generalised exanthematous pustulosis
  • hyperkalaemia
  • pulmonary embolism
  • pneumonia
  • cardiac arrest
  • neutropenia
  • pancytopenia
  • streptococcal sepsis
  • thrombocytopenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lovenox and Testosterone cypionate?

Can you answer these questions?

More questions for: Lovenox, Testosterone cypionate

You may be interested in these reviews

More reviews for: Lovenox, Testosterone cypionate

On eHealthMe, Lovenox (enoxaparin sodium) is often used to treat deep venous thrombosis. Testosterone cypionate (testosterone cypionate) is often used to treat testosterone. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.